Clinical Trial Policies


The Argentine Journal of Cardiology requires that all clinical trials submitted for evaluation strictly adhere to the guidelines of the International Committee of Medical Journal Editors (ICMJE) and the principles of the Declaration of Helsinki. It is a mandatory requirement that the study has been approved by an accredited Ethics Committee, that participants have signed informed consent forms, (see Human Subjects and Animal Rights in Scientific Research Policy) and that the trial is registered in a public, prospective registry (such as ClinicalTrials.gov or the WHO platform) prior to the enrollment of the first patient. The registry name and identification number must be explicitly stated in both the Abstract and the Materials and Methods section of the manuscript.
To ensure methodological quality, authors must structure the article according to the CONSORT guidelines, attaching the corresponding checklist and including the patient flow diagram within the body of the text. Furthermore, the manuscript must include a transparent statement regarding the data sharing policy, detailing whether anonymized raw data will be made available and under what conditions for scientific access.
Finally, transparency regarding funding is a mandatory condition for publication. All authors must individually complete the ICMJE Conflict of Interest Disclosure Form, explicitly reporting any commercial ties, consultancy arrangements, provision of supplies, or direct or indirect financial support from the pharmaceutical or medical device industries. Failure to comply with any of these requirements will result in the immediate rejection of the manuscript during the initial editorial review phase.